eRAD adds uniRAD to RIS/PACS release

Sarah Lamberti | | Health Exec | Precision Medicine
eRAD has released version 6.2 of its RIS/PACS, which includes a Web-based workflow consolidation and interoperability platform, uniRAD.

With customizable preferences and automated processes, uniRAD provides physicians with a single point of access to information stored across different systems in numerous locations, the company said.

The Greenville, S.C.-based company said that depending on the configuration, tools such as scheduling, dictation, transcription and report distribution can co-exist with other solutions, allow for incorporation of non-integrated imaging sites, temporary alliances or loosely associated users.

uniRAD is designed to offer multi-site, multi-vendor PACS integration, with optional storage configurations, according to Roy W. Miller, MD, president and CEO, eRAD.



Sarah Lamberti

Related Content

Pitching the business case for 3D printing labs in radiology
FDA issues first-ever clearance for OTC oximeter
Augmented reality company secures $15M in funding from Cleveland Clinic, Mayo, GE Healthcare and more
Merck to acquire Prometheus Biosciences for $10.8B
Johnson & Johnson scraps RSV vaccine after trial
Intermountain Health launches new biotech company

Around the web

Cardiovascular Business
Boston Scientific enters renal denervation market with acquisition worth up to $540M

Boston Scientific has announced another significant M&A deal, scooping up an Israeli medtech company focused on RDN technology. 

Radiology Business
Shift toward imaging outside the hospital could save billions

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Cardiovascular Business
FDA announces catheter recall for Johnson & Johnson PFA system due to stroke risk

The recall comes after approximately 3% of patients treated with the device during the early stages of its U.S. rollout experienced a stroke or transient ischemic attack following surgery. The expected stroke rate is closer to 1%, the FDA explained.